Tirzepatide (Mounjaro) works similarly but is classified as a dual GIP/GLP-1 receptor agonist
SHINODA, H., ITO, K., MATSUNAGA, T., TAKADA, T., & NOMURA, T
This modification allows the peptide to bind to amylin receptor subtypes 1 and 3 in the brain, specifically in the area postrema of the hindbrain, producing sustained appetite reduction without the peaks and valleys that come with shorter-acting compounds
Conclusions These findings demonstrate that Oral HS lipo enables effective, site-specific delivery of HS to inflamed colonic tissue, offering a clinically relevant platform to overcome limitations of conventional HS donor therapies in IBD management
Before initiating therapy with Zepbound or Ozempic, our providers will thoroughly review your medical history, current medications, and any other health concerns to ensure these treatments are safe and suitable for you
2024;11:e2402890